ARIAD Pharmaceuticals Inc (ARIA.OQ)
ARIA.OQ on NASDAQ Stock Exchange Global Select Market
18.84USD
11:51am EDT
18.84USD
11:51am EDT
Price Change (% chg)
$0.26 (+1.40%)
$0.26 (+1.40%)
Prev Close
$18.58
$18.58
Open
$18.78
$18.78
Day's High
$18.94
$18.94
Day's Low
$18.71
$18.71
Volume
87,283
87,283
Avg. Vol
627,660
627,660
52-wk High
$25.39
$25.39
52-wk Low
$15.35
$15.35
About
ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia... (more)
Overall
| Beta: | 1.27 |
| Market Cap (Mil.): | $3,431.54 |
| Shares Outstanding (Mil.): | 184.69 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ARIA.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 37.93 | 37.76 |
| EPS (TTM): | -1.35 | -- | -- |
| ROI: | -68.17 | 19.48 | 18.76 |
| ROE: | -73.93 | 20.17 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Takeda Pharmaceutical Company Limited (4502.T) | ¥4,580 | +205.00 |
| Astellas Pharma Inc (4503.T) | ¥5,340 | +90.00 |
| CHUGAI PHARMACEUTICAL CO., LTD. (4519.T) | ¥1,988 | +43.00 |
| Johnson & Johnson (JNJ.N) | $94.09 | +0.59 |
| Pfizer Inc. (PFE.N) | $29.08 | -0.15 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| Merck & Co., Inc. (MRK.N) | $48.24 | +0.07 |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| Sanofi SA (SASY.PA) | €76.85 | -3.32 |
| AstraZeneca plc (AZN.L) | 3,334.00p | -1.00 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

